Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2026-02-26 @ 12:05 PM
Study NCT ID:
NCT05317403
Status:
RECRUITING
Last Update Posted:
2024-11-26
First Post:
2022-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Sponsor:
Medical College of Wisconsin
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Venetoclax Epigenetic
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None